Andreas H. Groll, Dominik Schrey, Athanasios Tragiannidis, Konrad Bochennek and Thomas Lehrnbecher Pages 3545 - 3568 ( 24 )
Invasive aspergillosis is an important cause of morbidity and mortality in immunocompromised children. Disease control depends on prevention, early diagnosis, predictive microbiological information, prompt and appropriate treatment and restoration of host defenses. Relative to adults, invasive aspergillosis in children and adolescents is unique in its clinical presentation, epidemiology, and in particular, the utility of newer diagnostic tools and the pharmacokinetics of active antifungal agents. Here we review the presentation and epidemiology of invasive aspergillosis in children and adolescents and discuss the value of current diagnostic tools and strategies and options for treatment and prevention in this special population.
Mycoses, aspergillosis, children, adolescents, cancer, bone marrow transplantation, solid organ transplantation, immunodeficiency.
, , , , Infectious Disease Research Program Ctr for Bone Marrow Transplantation and Dept. of Pediatric Hematology/ Oncology University Children’s Hospital Muenster Albert- Schweitzer-Strasse 33 48149 Muenster, Germany.